Mirari Biosciences, Inc.

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 100.0

EPO Patents = 1

Forward Citations = 142

Loading Chart...

2 inventors (with patents filed for the assignee):

Mark T Martin (6 out of 52 patents)

Richard G Saul (2 out of 7 patents)

6 patents: Sort by Forward Citations

1. 8431414 - Methods and compositions for directed microwave chemistry (2013-04-30),

2. 8309367 - Microwave microfluidics (2012-11-13),

3. 7718445 - Methods and compositions for directed microwave chemistry (2010-05-18),

4. 7351590 - Methods and compositions for directed microwave chemistry (2008-04-01),

5. 7348182 - Directed microwave chemistry (2008-03-25),

6. 7169894 - Methods and compositions for reverse translation (2007-01-30),

Company Overview

Mirari Biosciences, Inc. is a biotechnology company focused on developing innovative cancer therapies. With a strong emphasis on precision medicine, Mirari is dedicated to advancing the field of oncology through groundbreaking research and cutting-edge technologies. The company's mission is to improve patient outcomes and quality of life by delivering targeted treatments that address the underlying mechanisms of cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#93 in Rockville, MD

#635 in Maryland

#45,030 in US

Rockville, MD, United States of America

Mirari Biosciences, Inc.

Forward Citations = 142

2 inventors:

Mark T Martin (6 out of 52 patents)

Richard G Saul (2 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mirari Biosciences, Inc.. Retrieved from https://idiyas.com/company/mirari-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]